Related Experiment Video
Updated: Jul 19, 2026
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
68 Ga-FAPI PET/CT Depicted Non-FDG-Avid Malignant Peritoneal Mesothelioma
Puhao Li1, Juan Liang2, Yue Chen
1Southwest Medical University, Luzhou, Sichuan, China.
Abstract:
Malignant peritoneal mesothelioma (MPM) is a rare and aggressive malignancy of mesothelial cells in the peritoneum. Herein, we describe the 68 Ga-FAPI and 18 F-FDG PET/CT findings of MPM in a 41-year-old man. In the present case, the primary and metastatic tumors showed intense 68 Ga-FAPI accumulation but no significantly increased 18 F-FDG uptake. This case demonstrates that 68 Ga-FAPI PET/CT might be used as a helpful tool for evaluating MPM staging.
Insights
This study highlights 68 Ga-FAPI PET/CT findings in malignant peritoneal mesothelioma (MPM). The imaging agent showed high tumor uptake, suggesting its potential utility in MPM staging.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiology
Background:
- Malignant peritoneal mesothelioma (MPM) is a rare and aggressive cancer.
- Accurate staging is crucial for effective treatment planning in MPM.
Purpose of the Study:
- To describe the Positron Emission Tomography/Computed Tomography (PET/CT) findings using 68 Ga-FAPI and 18 F-FDG in a patient with MPM.
- To evaluate the potential role of 68 Ga-FAPI PET/CT in MPM staging.
Main Methods:
- A case study of a 41-year-old male patient with MPM.
- Utilized 68 Ga-FAPI and 18 F-FDG PET/CT for imaging.
- Analyzed tracer accumulation in primary and metastatic tumors.
Main Results:
- Intense accumulation of 68 Ga-FAPI was observed in both primary and metastatic MPM lesions.
- Significantly increased uptake of 18 F-FDG was not detected in the tumors.
- This differential uptake pattern was noted in the MPM case.
Conclusions:
- 68 Ga-FAPI PET/CT demonstrates high tumor uptake in malignant peritoneal mesothelioma.
- 68 Ga-FAPI PET/CT may serve as a valuable tool for staging MPM.
- Further research is warranted to confirm the utility of 68 Ga-FAPI in MPM management.
![An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg&w=3840&q=50)
